Literature DB >> 16371024

NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.

Ana I Romero1, Fredrik B Thorén, Mats Brune, Kristoffer Hellstrand.   

Abstract

The cytotoxicity of natural killer (NK) cells is dependent on the interaction between target cell ligands and a series of stimulatory receptors on NK cells. Two of these triggering receptors, the NKp46 natural cytotoxicity receptor (NKp46) and the major histocompatibility complex (MHC) class I-interactive NKG2D receptor, are deficiently expressed by NK cells recovered from patients with acute myeloid leukaemia (AML), but little is known regarding the regulation of NKp46 and NKG2D expression. Here we report that mononuclear and polymorphonuclear phagocytes downregulate the cell surface density of NKp46 and NKG2D on NK cells with CD56(dim) phenotype in vitro by a mechanism that is dependent on the availability of phagocyte-derived reactive oxygen species (ROS). Histamine maintained NKp46 and NKG2D expression despite the presence of inhibitory phagocytes by targeting an H2 receptor on phagocytes. By contrast, NKp46 and NKG2D expression by the CD56(bright) subset of NK cells was resistant to inhibition by phagocytes. Our findings are suggestive of a novel mechanism of relevance to the regulation of NKp46/NKG2D receptor expression. Moreover, our findings suggest that the previously reported action of histamine on NK cell-mediated killing of leukaemic cells may be related to the preservation of activatory NK-cell receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16371024     DOI: 10.1111/j.1365-2141.2005.05842.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

1.  Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells.

Authors:  Yasuhiro Nagai; Yukinori Tanaka; Toshinobu Kuroishi; Ryutaro Sato; Yasuo Endo; Shunji Sugawara
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

2.  Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

Authors:  Jeffrey M Milush; Brian R Long; Jennifer E Snyder-Cappione; Amedeo J Cappione; Vanessa A York; Lishomwa C Ndhlovu; Lewis L Lanier; Jakob Michaëlsson; Douglas F Nixon
Journal:  Blood       Date:  2009-10-05       Impact factor: 22.113

Review 3.  Mechanisms regulating immune surveillance of cellular stress in cancer.

Authors:  Ruth Seelige; Stephen Searles; Jack D Bui
Journal:  Cell Mol Life Sci       Date:  2017-07-25       Impact factor: 9.261

4.  Prmt1 upregulated by Hdc deficiency aggravates acute myocardial infarction via NETosis.

Authors:  Zhiwei Zhang; Suling Ding; Zhe Wang; Xiaowei Zhu; Zheliang Zhou; Weiwei Zhang; Xiangdong Yang; Junbo Ge
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

5.  Effects of reactive nitrogen scavengers on NK-cell-mediated killing of K562 cells.

Authors:  Yili Zeng; Qinmiao Huang; Meizhu Zheng; Jianxin Guo; Jingxin Pan
Journal:  J Biomed Biotechnol       Date:  2012-02-05

Review 6.  Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity.

Authors:  Anne-Sophie Chretien; Aude Le Roy; Norbert Vey; Thomas Prebet; Didier Blaise; Cyril Fauriat; Daniel Olive
Journal:  Front Immunol       Date:  2014-03-24       Impact factor: 7.561

7.  Natural killer cells modulation in hematological malignancies.

Authors:  Céline Baier; Aurore Fino; Carole Sanchez; Laure Farnault; Pascal Rihet; Brigitte Kahn-Perlès; Régis T Costello
Journal:  Front Immunol       Date:  2013-12-19       Impact factor: 7.561

8.  Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

Authors:  Trinidad Garcia-Iglesias; Alicia Del Toro-Arreola; Benibelks Albarran-Somoza; Susana Del Toro-Arreola; Pedro E Sanchez-Hernandez; Maria Guadalupe Ramirez-Dueñas; Luz Ma Adriana Balderas-Peña; Alejandro Bravo-Cuellar; Pablo C Ortiz-Lazareno; Adrian Daneri-Navarro
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

Review 9.  Tumor-primed NK cells: waiting for the green light.

Authors:  May Sabry; Mark W Lowdell
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

10.  Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.

Authors:  Ali A Akhiani; Olle Werlenius; Johan Aurelius; Charlotta Movitz; Anna Martner; Kristoffer Hellstrand; Fredrik B Thorén
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.